drugset / Trial / NCT05634447

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

NCT05634447

Phase 1 Completed 69 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391

Timeline

Start
2022-12-20
Primary completion
2023-02-27
Completion
2023-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-331 Unknown Oral
Subject CKD-391 Unknown Oral
Subject D337 Unknown Oral

Indications